Generation and phenotypic analysis of protein S-deficient mice

Blood

Volumn 114, Issue 11, 2009, Pages 2307-2314

  Saller, François ^a   Brisset, Anne C ^a   Tchaikovski, Svetlana N ^b   Azevedo, Monica ^a   Chrast, Roman ^c   Fernández, José A ^d   Schapira, Marc ^a   Hackeng, Tilman M ^b   Griffin, John H ^d   Angelillo Scherrer, Anne ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PROTEIN C; PROTEIN S; THROMBIN; TISSUE FACTOR PATHWAY INHIBITOR; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD CLOTTING; BRAIN HEMORRHAGE; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MODEL; DISSEMINATED INTRAVASCULAR CLOTTING; EMBRYO; EXON; FEMALE; FIBRIN DEPOSITION; GENE TARGETING; HETEROZYGOTE; IN VIVO STUDY; LIFE; LIVER; MALE; MATING; MEGAKARYOCYTE; MOUSE; NONHUMAN; NULL ALLELE; PARENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS; ANIMAL; FETUS DEATH; GENETICS; HUMAN; METABOLISM; MORTALITY; MOUSE MUTANT; PATHOLOGY; PROTEIN S DEFICIENCY;

ANIMALS; DISEASE MODELS, ANIMAL; FETAL DEATH; HETEROZYGOTE; HUMANS; INTRACRANIAL HEMORRHAGES; LIPOPROTEINS; LIVER; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; PROTEIN C; PROTEIN S; PROTEIN S DEFICIENCY; THROMBIN; THROMBOEMBOLISM;

EID: 70349575804     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-03-209031     Document Type: Article

References (43)

1. Gandrille S, Borgel D, Sala N, et al. Protein S deficiency: a database of mutations: summary of the first update. Thromb Haemost. 2000;84:918.
2. Gomez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM. Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost. 1994;71:723-726. (Pubitemid 24177959)
3. Mahasandana C, Veerakul G, Tanphaichitr VS, Suvatte V, Opartkiattikul N, Hathaway WE. Homozygous protein S deficiency: 7-year follow-up. Thromb Haemost. 1996;76:1122. (Pubitemid 27013661)
4. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet. 2001;109:369-384. (Pubitemid 33064516)
5. Heeb MJ, Gandrille S, Fernandez JA, Griffin JH, Fedullo PF. Late onset thrombosis in a case of severe protein S deficiency due to compound heterozygosity for PROS1 mutations. J Thromb Haemost. 2008;6:1235-1237. (Pubitemid 351859137)
6. D'Angelo A, Vigano D'Angelo S. Protein S deficiency. Haematologica. 2008;93:498-501.
7. Garcia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost. 2007;98:543-556.
8. Castoldi E, Hackeng TM. Regulation of coagulation by protein S. Curr Opin Hematol. 2008;15:529-536.
9. Hackeng TM, Sere KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A. 2006;103:3106-3111. (Pubitemid 43346432)
10. Rosing J, Maurissen LF, Tchaikovski SN, Tans G, Hackeng TM. Protein S is a cofactor for tissue factor pathway inhibitor. Thromb Res. 2008;122(Suppl 1):S60-S63.
11. Ndonwi M, Broze G Jr. Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor. J Thromb Haemost. 2008;6:1044-1046. (Pubitemid 351689932)
12. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem. 1993;268:2872-2877. (Pubitemid 23057922)
13. Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A. 1994;91:2728-2732.
14. Rosing J, Hoekema L, Nicolaes GA, et al. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995;270:27852-27858.
15. Stitt TN, Conn G, Gore M, et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell. 1995;80:661-670.
16. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008;8:327-336.
17. Prasad D, Rothlin CV, Burrola P, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006;33:96-108. (Pubitemid 44291594)
18. Uehara H, Shacter E. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. J Immunol. 2008;180:2522-2530.
19. Angelillo-Scherrer A, de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med. 2001;7:215-221. (Pubitemid 32148489)
20. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2001;293:306-311. (Pubitemid 32694748)
21. Huang ZF, Higuchi D, Lasky N, Broze GJ Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 1997;90:944-951. (Pubitemid 27314126)
22. Jalbert LR, Rosen ED, Moons L, et al. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest. 1998;102:1481-1488. (Pubitemid 28492214)
23. Gu JM, Crawley JT, Ferrell G, et al. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J Biol Chem. 2002;277:43335-43343. (Pubitemid 35285721)
24. Rosenberg RD. The absence of the blood clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Thromb Haemost. 1995;74:52-57.
25. Liu P, Jenkins NA, Copeland NG. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 2003;13:476-484. (Pubitemid 36395405)
26. Warming S, Rachel RA, Jenkins NA, Copeland NG. Zfp423 is required for normal cerebellar development. Mol Cell Biol. 2006;26:6913-6922. (Pubitemid 44387640)
27. Dubois NC, Hofmann D, Kaloulis K, Bishop JM, Trumpp A. Nestin-Cre transgenic mouse line Nes-Cre1 mediates highly efficient Cre/loxP mediated recombination in the nervous system, kidney, and somite-derived tissues. Genesis. 2006;44:355-360. (Pubitemid 44384311)
28. Porret A, Merillat AM, Guichard S, Beermann F, Hummler E. Tissue-specific transgenic and knockout mice. Methods Mol Biol. 2006;337:185-205.
29. Fernandez JA, Xu X, Liu D, Zlokovic BV, Griffin JH. Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model. Blood Cells Mol Dis. 2003;30:271-276. (Pubitemid 36539428)
30. Tchaikovski SN, Van Vlijmen BJ, Rosing J, Tans G. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. J Thromb Haemost. 2007;5:2079-2086. (Pubitemid 47450027)
31. de Waard V, Hansen HR, Spronk HH, et al. Differential expression of tissue factor mRNA and protein expression in murine sepsis: the role of the granulocyte revisited. Thromb Haemost. 2006;95:348-353.
32. Weiss EJ, Hamilton JR, Lease KE, Coughlin SR. Protection against thrombosis in mice lacking PAR3. Blood. 2002;100:3240-3244.
33. Lee EC, Yu D, Martinez de Velasco J, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001;73:56-65. (Pubitemid 32382387)
34. Trumpp A, Refaeli Y, Oskarsson T, et al. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature. 2001;414:768-773. (Pubitemid 34000776)
35. Leon C, Freund M, Ravanat C, Baurand A, Cazenave JP, Gachet C. Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation. 2001;103:718-723. (Pubitemid 32144201)
36. Lay AJ, Liang Z, Rosen ED, Castellino FJ. Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities. J Clin Invest. 2005;115:1552-1561. (Pubitemid 40814663)
37. Emeis JJ, Jirouskova M, Muchitsch EM, Shet AS, Smyth SS, Johnson GJ. A guide to murine coagulation factor structure, function, assays, and genetic alterations. J Thromb Haemost. 2007;5:670-679. (Pubitemid 46563563)
38. Fernandez JA, Lentz SR, Dwyre DM, Griffin JH. A novel ELISA for mouse activated protein C in plasma. J Immunol Methods. 2006;314:174-181. (Pubitemid 44189422)
39. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 2000;96:4222-4226.
40. Maurissen LF, Thomassen MC, Nicolaes GA, et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 2008;111:3034-3041.
41. Dahlback B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem. 1986;261:12022-12027. (Pubitemid 17202758)
42. Heeb MJ, Koenen RR, Fernandez JA, Hackeng TM. Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals. J Thromb Haemost. 2004;2:1766-1773.
43. Rodriguez de Cordoba S, Perez-Blas M, Ramos-Ruiz R, Sanchez-Corral P, Pardo-Manuel de Villena F, Rey-Campos J. The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse. Genomics. 1994;21:501-509. (Pubitemid 24189880)